George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 1.00 (1.77%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 57.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter Results

24 Nov 2023 07:00

RNS Number : 5276U
British Smaller Companies VCT2 Plc
24 November 2023
 

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 30 September 2023

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 30 September 2023. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

 

Overview

In the quarter to 30 September 2023, the Company generated a 0.8 per cent return on its opening Net Asset Value of 57.95 pence, compared to a 0.1 per cent rise in the FTSE Small Cap.

The Company's Total Return at 30 September 2023 was up 0.45 pence at 143.15 pence per ordinary share.

During the quarter, the Company invested £1.6 million into GEEIQ, a data and market intelligence platform in the gaming space. The Company has also invested a further £0.2 million into Elucidat.

Following the quarter end, a £0.5 million follow-on investment into Force24 has been completed, taking the total invested in the current financial year to £9.7 million, following the £16.3 million invested in 2022.

Post-period end, in November 2023, the Company exited its investments in E2E, a consultancy in the satellite industry, for £1.4 million, representing a 2.5x return on the Company's cost; and MacroArt, a large scale branding and signage specialist, for £1.0 million, representing a 2.0x return on the Company's cost. This was a pleasing outcome for the Company following a challenging hold period, and reflects the Company's ethos of working hard to generate positive returns from all of its investments.

Performance

The movement in Total Return in pence per ordinary share is set out in the table below:

 

 

30 June 2023

Increase in value

Buy-back of shares

Movement

in period

30 Sept 2023

Net Assets (£m)

133.0

1.0

(0.5)

0.5

133.5

NAV per share (PPS)

57.95p

0.45p

-

0.45p

58.40p

Cumulative dividends paid (PPS)

84.75p

-

-

-

84.75p

Total Return (PPS)

142.7p

0.45p

-

0.45p

143.15p

Shares in issue

229,484,783

-

(907,200)

(907,200)

228,577,583

 

The movements in NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 30 June 2023

133.0

57.95

Increase in portfolio value

1.4

0.6

Net operating costs

(0.2)

(0.05)

Incentive fee

(0.2)

(0.1)

1.0

0.45

Buy-back of shares

(0.5)

-

Total Return in the period

0.5

0.45

NAV at 30 September 2023

 

133.5

 

58.40

 

Post-period end, on 3 November 2023, a second interim dividend of 1.5 pence per ordinary share for the year ending 31 December 2023 was paid, taking cumulative dividends paid to paid to 86.25 pence per ordinary share and resulting in a corresponding reduction to the 30 September 2023 unaudited NAV, to 56.90 pence per ordinary share.

Buy-backs, dividends and shares in issue

On 25 September 2023, the Company purchased 907,200 ordinary shares of 10 pence each at a price of 55.55 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 30 September 2023 was 228,577,583 (30 June 2023: 229,484,783). In addition, at 30 September 2023 the Company held 20,449,923 ordinary shares in treasury (30 June 2023: 19,542,723).

Subsequent to the quarter end, on 3 November 2023 the Company issued 1,114,927 shares under the Company's Dividend Re-investment Scheme (DRIS) following the payment of the interim dividend, taking the number of shares in issue at that date to 229,692,510, with a further 20,449,923 shares held in treasury.

Net assets

Net assets at 30 September 2023 comprised the following:

£000

% of net assets

Unquoted investments at fair value

92,274

69.1

Listed investment funds

1,698

1.3

Cash and cash equivalents

39,273

29.4

Other net current assets

269

0.2

Net assets

133,514

100.0

 

Investments

The investment portfolio at 30 September 2023 comprised:

Valuation

£000

Cumulative valuation as a % of net assets

Matillion

21,314

16.0%

Unbiased

7,708

21.7%

Outpost

5,957

26.2%

Displayplan

4,637

29.7%

Elucidat

4,330

32.9%

Wooshii

4,004

35.9%

Force24

3,195

38.3%

ACC Aviation

2,949

40.5%

Vypr

2,746

42.6%

Quality Clouds

2,628

44.5%

59,468

44.5%

Other investments

32,806

69.1%

Total investments

92,274

69.1%

 

Shareholder relations

The Company will be hosting an online webinar on 27 November 2023 to provide an update to shareholders; for further details please contact Tracey Nice at tracey.nice@yfmep.com.

Regulatory Developments

In the Autumn Statement on 22 November 2023, the Government announced it would extend the sunset clause currently in place for Venture Capital Trusts until April 2035, and that it would include legislation to achieve this in the next Finance Bill.

Fundraising

Having assessed its expected cash requirements, the Company announced a new share offer on 20 September 2023, alongside British Smaller Companies VCT plc, with the intention of raising up to £90 million (in aggregate), which includes an over-allotment facility of £25 million. Applications exceeding £45 million have been received as of the date of this report, of which £18 million relate to the Company. The first allotment of £30 million of gross proceeds will take place between 29 and 31 January 2024. The second and final allotment will take place in early April 2024.

Outlook

The UK macro-economic environment has stabilised somewhat and the economy may well avoid a recession, although growth levels are likely to remain weak. And while rates of inflation are expected to reduce, interest rates are anticipated to remain at the current elevated levels for some time. Portfolio companies have coped well in this environment, and continue to grow revenues, which helps to offset the impact on the Company of muted valuations multiples. It has also been pleasing to continue to achieve good realisations of portfolio companies and we feel the Company's investments are well placed to deliver further exits in the coming quarters.

We continue to see opportunities to deploy capital into promising new businesses, as well as to continue funding existing portfolio companies to help them scale up their growth plans. 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

24 November 2023

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTPPGPPGUPWGRW
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.